MEPRATE

Active substance: MEPROBAMATE

View full screen / Print PDF » Download PDF ⇩

Transcript
PATIENT INFORMATION LEAFLET

MEPRATE
W hat is in your m edicine?
The name of this medicine is Meprate. Each tablet contains
400 mg Meprobamate together with the ingredients maize
starch, pre-gelatinised maize starch, sodium lauryl sulphate,
sodium starch glycollate, and magnesium stearate.
Your tablets are white, round, flat with bevelled edges and a
break-line on one face and are 11 mm in diameter.
Meprate is available in plastic pots of 100 and 500 tablets.
How does Meprate work?
Meprate belongs to a group of medicines known as
tranquilisers and sedatives.
The name and address of the Product Licence holder of
Meprate is: Chelonia Healthcare Limited, Boumpoulinas 11,
3rd Floor, Nicosia, P.C. 1060, Cyprus.
The manufacturer of Meprate is: DDSA Pharmaceuticals
Ltd., Chatfield Road, off York Road, Battersea, London
SW11 3SE.
Treatment with Meprate
Meprate is used in the short-term treatment for the symptoms
of anxiety states and where muscle tension is prominent.
Check before you take these Meprate tablets
Before taking these tablets, tell your doctor if you have ever
had any unusual or allergic reactions to Meprate or any of
the other ingredients of these tablets.
Also tell your doctor or pharmacist if you are allergic to any
other substances such as foods, preservatives or dyes.
Do not take Meprate if you have a known sensitivity to
medicines related to Meprate such as Carisoprodol or
Carbromal.
Do not take this medicine if you suffer from a condition
known as porphyria, if you are breast-feeding, if you suffer
from breathing problems such as asthma, if you are inclined
to use any so-called drugs of abuse, or if you indulge in
excessive amounts of alcohol.
Tell your doctor if you suffer from epilepsy, muscle
weakness, liver or kidney problems.
Because the presence of other medicines may affect the
action of these tablets, make sure to tell your doctor if you
are taking any other medicines such as anti-coagulants
(blood thinners); steroids (including oral contraceptives);
phenytoin (used in epilepsy); griseofulvin (used for fungal
infections); a group of drugs known as the phenothiazines
(which include medicines such as chlorpromazine,
trifluoperazine, promethazine and others); rifampicin (an
antibiotic); a group of drugs known as the tri-cyclic antidepressants which include imipramine, amitriptyline and
others.

Use in pregnancy
Meprate passes into the breast milk and may cause
drowsiness in babies or mothers taking this medicine.
Let your doctor know if you are pregnant, planning to
become pregnant or are breast-feeding.

Effects of Meprate on the ability to drive and use
machines
Performance at skilled tasks and alertness may be impaired
and, because these tablets may cause drowsiness, they may
affect the ability to drive or operate machinery. These
effects may be increased by the use of alcohol. For this
reason, avoid driving or operating machinery whilst taking
this medicine.
Proper use of this medicine
Take this medicine by mouth and only in the doses
prescribed by your doctor. Do not take more of it and do not
take it more often or for a longer time than your doctor
ordered.
If you miss a dose, skip the missed dose and go back to your
regular dosing schedule. Do not take two doses at once.
Dosage: This medicine is to be taken by mouth.
Adults: The usual dosage is 400-1600 mg daily in divided
doses. Higher doses are not recommended.
Elderly: Half the normal adult dose or less may be
sufficient in the elderly.
Children: Not recommended.
Dependence may occur when Meprate is taken in higher than
recommended doses, for long periods. It may also occur in
persons dependent on alcohol or other drugs of dependence.
Withdrawal reactions may occur which vary in severity from
insomnia and confusion to convulsions (seizures) and coma.
Treatment should be withdrawn gradually.
Overdosage
If you think you may have taken too many of your tablets,
either call your doctor straight away, or go to the nearest
hospital casualty department. Always keep any remaining
tablets in the container in which they were given to you, and
also the label so that the medicine can be identified by the
doctor or pharmacist in the hospital.
Also tell them whether you have taken any other medicines.
The symptoms of overdose are shock, coma, difficulty in
breathing.
Undesirable effects that may occur with the use of
this medicine
The most common undesirable effects that have been
described are drowsiness and sedation, unsteadiness,
dizziness, fainting, inco-ordination, sickness, vomiting,
diarrhoea and constipation, alteration of speech, headache,
heart palpitations, fainting, pins and needles in the fingers

and toes, blurred vision, excitement, undue feeling of
elation, rapid heartbeat.
Hypersensitivity reactions may occur after a single tablet and
in patients who have not previously taken this medicine.
These reactions may include skin reactions such as urticaria
(hives), itchy small red nodules or patches of red rashes
which may cover parts of the body or the whole body.
Occasionally reactions with shaking, chills and fever,
nausea, vomiting, a fall in blood pressure.
Meprate can reduce the number of certain types of blood
cells. If you get a bad sore throat or high fever or become
gradually more tired or tired and pale, or notice bruises or
nosebleeds, stop taking Meprate and contact your doctor at
once.
Rarely, the following hypersensitivity reactions
may occur:
Raised temperature, swelling of the soft tissues of the mouth
and throat, breathing difficulty caused by spasm of the lungs,
scanty passage of urine and absence of urine. Also shock, a
skin condition known as erythema multiforme, an eczema
type of skin condition, inflammation of the mouth.
If you notice any of the above symptoms, contact your
doctor immediately.
Storing your medicine
You must keep this medicine in a safe place where children
cannot get it. Your medicine could harm them.
Keep your medicine in a dry place and store below 25°C.
Keep container well-closed and protect from light.
If your doctor tells you to stop the treatment, return any
remaining tablets to the doctor or pharmacist.
On the label you will find the words “Expiry Date” followed
by numbers indicating the day, month and year. This is the
date when the medicine is no longer fit for use. Do not use
the medicine after this date, but return it to your doctor or
pharmacist.
A reminder
REMEMBER this medicine is for you. Never give it to
someone else, even if their condition is the same as yours.
This leaflet does not contain the complete information about
your medicine. If you have any questions or are not sure
about anything, ask your doctor or pharmacist who have
access to additional information.
PL 33414/0058
This Leaflet was revised in February 2009

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web5)